NSE filing, NSE: HCG. Summary written from the filing by ALFA Finder's alert engine.
Healthcare Global Enterprises Ltd: key numbers
- Share price
- ₹610.90
- Market cap
- ₹9,121 Cr
- Revenue (annual)
- ₹2,545 Cr
- Net profit (annual)
- ₹13.76 Cr
- P/E (TTM)
- 400.0×Sector 53.4×
- Promoter holding
- 64.21%+0.00% QoQ
- FII holding
- 2.70%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Healthcare Global Enterprises Ltd
All →Healthcare Global Enterprises Results Update
HCG reported Q2 FY27 revenue of INR 7,318 Mn, up 16% YoY, with adjusted EBITDA up 17%. Results cover the quarter and half-year ended September 30, 2026.
Healthcare Global Enterprises Investor Presentation: Key Takeaways
Q2 FY27 revenue INR 7,318 Mn (+16% YoY) and Adjusted EBITDA INR 1,425 Mn (+17%, 19.7% margin). Reported PAT INR 92.5 Mn. Plan to add 1,000 beds by FY30.
Healthcare Global Enterprises Employee Stock Options
HealthCare Global granted 70,000 employee stock options at a Rs 495 exercise price under its 2026 ESOS. Options vest within one to seven years.
- Execution
- Vesting 1 to 7 years from grant; exercisable for up to 10 years from grant
Healthcare Global Enterprises Q2 FY27 Results: Net Profit ₹9.2 Cr, Down 55.6% YoY
Healthcare Global Enterprises Ltd reported revenue from operations of ₹731.8 Cr (+13.1% YoY) and net profit of ₹9.2 Cr (-55.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹9.2 Cr · -55.6% YoY
Healthcare Global Enterprises Other Announcement
HealthCare Global Enterprises Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Healthcare Global Enterprises Board Meeting Date
HealthCare Global Enterprises will hold a board meeting on November 05, 2026, to consider and approve the unaudited financial results for the quarter ended September 30, 2026.
Other results update announcements
All →Avadh Sugar & Energy Results Update
Avadh Sugar & Energy reported Q2 FY27 revenue of Rs.652 Cr and PAT of Rs.10 Cr. H1 FY27 EBITDA rose to Rs.80 Cr from Rs.49 Cr.
Inventurus Knowledge Solutions Results Update
IKS Health reported strong Q2 FY27 revenue and EBITDA growth year-on-year, with TruBridge integration adding scale. The release also highlighted new US healthcare customer wins.
Gokaldas Exports Results Update
Gokaldas Exports issued a press release on unaudited Q2 and H1 FY27 results, reporting consolidated total income of ₹1,135 crore (up 13% YoY) and EBITDA of ₹127 crore. The release includes a P&L highlights table with Total Income, EBITDA and PAT rows.
Prime Industries Results Update
Prime Industries released Q2 FY27 highlights: revenue ₹24.99 crore, PAT ₹6.62 crore. Figures come from unaudited consolidated results for the period ended September 30, 2026.
INDO SMC Results Update
Indo SMC reported H1FY27 total income up 94% to ₹218 crore and net profit up 76% year-on-year. The release also highlights an order book of ₹145 crore.
Safari Industries (India) Results Update
Safari Industries posted Q2FY27 revenue up 9.1% to ₹582.22 crore and PAT of ₹36.93 crore. It also approved capex of up to ₹230 crore for capacity expansion.
- combined production capacity
- 18.0 lakh pieces per month